1+ hour, 51+ min ago   (283+ words) The regulatory burden of new clinical trials has slowed progress. Dr. Ruxandra Teslo, a genomics researcher, identifies “[T]he Biggest Obstacle to New Cancer Cures” in an op-ed for NYT. The cost of running a clinical trial in the United…...

1+ hour, 45+ min ago   (494+ words) SUNNYVALE, CA / ACCESS Newswire / September 5, 2026 / opAIda, an enterprise artificial intelligence company focused on transforming complex, knowledge-intensive workflows, today celebrated the grand opening of its Silicon Valley office at Plug and Play Tech Center in Sunnyvale, California. The opening marked more…...

5+ hour, 15+ min ago   (1104+ words) Canadian biotechnology has moved past the pandemic-era spotlight and into a phase of sustained maturity. The companies that dominate the sector in 2026 are not the same ones that led it five years ago. What we see now is a mix…...

7+ hour, 48+ min ago   (204+ words) Medicines Discovery Catapult (MDC) has invested in Flip Therapeutics and Nascent Therapeutics as part of an Innovate UK-backed initiative designed to support high-potential UK life science companies. Each company will receive £500,000 in funding, alongside access to MDC’s translational drug discovery expertise,…...

17+ hour, 15+ min ago   (184+ words) Initiative to connect science, capital and industry for scaling innovations BIO NIVESH biotech funding platform 5 Sept 2026 5:10 AM IST He further said that ‘BIO-NIVESH’ would help build the bridge required to take promising ideas from research and entrepreneurship to industry, scale…...

10+ hour, 8+ min ago   (423+ words) The Clinical Trial Vanguard AI Agents in Clinical Trials Require Human Review Before Data Commits A phase 3 protocol in 2020 collected an average of 3.56 million data points. By 2025 that number had climbed to 5.96 million, a 67% rise in five years and more…...

21+ hour, 44+ min ago   (263+ words) Wednesday, October 28 at 10:00 GMT | 11:00 CET | 06:00 EDT | 03:00 PDT Three-dimensional cell models, including organoids, are increasingly being adopted in drug discovery and disease research due to their ability to better replicate human biology than traditional 2D cultures. However, many researchers face challenges when…...

13+ hour, 45+ min ago   (343+ words) | Newswise Newswise A fourth T6SS in clinical Pseudomonas aeruginosa deploys the pore-forming effector TseMt Model of H4-T6SS-mediated TseMt delivery and function in clinical Pseudomonas aeruginosa LYSZa7 Newswise — This study was led by Tao Dong at the Department of Immunology and Microbiology, School…...

17+ hour, 52+ min ago   (926+ words) Scientific communication is becoming a technology problem as much as a content one. Life sciences teams work across complex data, regulatory requirements and specialized audiences, while the volume of material they need to turn into presentations and other communications continues…...

23+ hour, 26+ min ago   (263+ words) image: Screenshot of AIMe tool. view more Screenshot of AIMe tool. The human body and its gut microbiome produce thousands of small molecules that shape how the body functions—influencing immunity, metabolism, and more. Identifying what those molecules actually are…...